Dermatoloxía
Servizo
Hospital Vall d'Hebron
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (22)
2024
-
Exposome and basal cell carcinoma: a multicenter case–control study
International Journal of Dermatology
-
[Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245
2023
-
A multicenter case-control study comparing sun exposure habits and use of photoprotection measures in patients diagnosed with different types of skin cancer
Photodermatology Photoimmunology and Photomedicine, Vol. 39, Núm. 5, pp. 457-465
-
Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS Study
Dermatology (Basel, Switzerland), Vol. 239, Núm. 5, pp. 685-693
-
Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study
Actas Dermo-Sifiliograficas
-
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study
Actas Dermo-Sifiliograficas, Vol. 114, Núm. 7, pp. T565-T571
-
The DERMACLEAR study: Verification results of a natural language processing system in dermatology
JEADV Clinical Practice, Vol. 2, Núm. 4, pp. 775-785
-
The Influence of the Exposome in the Cutaneous Squamous Cell Carcinoma, a Multicenter Case–Control Study
Cancers, Vol. 15, Núm. 22
2022
-
Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases*
British Journal of Dermatology, Vol. 186, Núm. 1, pp. 142-152
2021
-
Effects of covid-19 lockdown on tumour burden of melanoma and cutaneous squamous cell carcinoma
Acta Dermato-Venereologica, Vol. 101, Núm. 8
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
2020
-
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases
British Journal of Dermatology, Vol. 183, Núm. 1, pp. 71-77
-
Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study
Dermatologic Therapy, Vol. 33, Núm. 6
2019
-
Análisis de la proporción de derivaciones potencialmente evitables desde Atención Primaria a Dermatología por lesiones quísticas o tumorales benignas en España. Datos del estudio DIADERM
Actas dermo-sifiliograficas, Vol. 110, Núm. 8, pp. 659-665
-
Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)
The Journal of antimicrobial chemotherapy, Vol. 74, Núm. 10, pp. 3044-3048
-
Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study
Journal of Dermatological Treatment, Vol. 30, Núm. 5, pp. 461-465
2017
-
Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts
British Journal of Dermatology, Vol. 176, Núm. 3, pp. 643-649
2015
-
A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk
Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881
-
Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis
Pharmacogenomics Journal, Vol. 15, Núm. 4, pp. 322-325
2013
-
Prevalence of dystrophic epidermolysis bullosa in Spain: A population-based study using the 3-source capture-recapture method. Evidence of a need for improvement in care
Actas Dermo-Sifiliograficas, Vol. 104, Núm. 10, pp. 890-896